Skip to main content
Top
Published in: Medical Microbiology and Immunology 3/2005

01-05-2005 | Original Investigation

Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin

Authors: Xiaogang Hou, Edgar Suquilanda, Ana Zeledon, Apollo Kacsinta, Akila Moore, Joseph Seto, Nancy McQueen

Published in: Medical Microbiology and Immunology | Issue 3/2005

Login to get access

Abstract

With the emergence of new viruses, such as the SARS virus and the avian influenza virus, the importance of investigations on the genetic basis of viral infections becomes clear. Sendai virus causes a localized respiratory tract infection in rodents, while a mutant, F1-R, causes a systemic infection. It has been suggested that two determinants are responsible for the systemic infection caused by F1-R [Okada et al (1998) Arch Virol 143:2343–2352]. The primary determinant of the pantropism is the enhanced proteolytic cleavability of the fusion (F) protein of F1-R, which allows the virus to undergo multiple rounds of replication in many different organs, whereas wild-type virus can only undergo multiple rounds of replication in the lungs. The enhanced cleavability of F1-R F was previously attributed to an amino acid change at F115 that is adjacent to the cleavage site at amino acid 116. Secondly, wild-type virus buds only from the apical domain of bronchial epithelium, releasing virus into the lumen of the respiratory tract, whereas F1-R buds from both apical and basolateral domains. Thus, virus is released into the basement membrane where it can easily gain access to the bloodstream for dissemination. The microtubule disruption is attributed to two amino acid differences in M protein. To confirm that the F and M gene mutations described above are solely responsible for the phenotypic differences seen in wld-type versus F1-R infections, reverse genetics was used to construct recombinant Sendai viruses with various combinations of the mutations found in the M and F genes of F1-R. Plaque assays were performed with or without trypsin addition. A recombinant virus containing all F1-R M and F mutations formed plaques in LLC-MK2 cells and underwent multiple cycles of replication without trypsin addition. To clarify which mutation(s) are necessary for plaque formation, plaque assays were done using other recombinant viruses. A virus with only the F115 change, which was previously thought to be the only change important for plaque formation of F 1-R F, did not confer upon the virus the ability to form plaques without the addition of trypsin. Another virus with the F115 and both M changes gave the same result. Therefore, more than one mutation in the F gene contributes to the ability of F1-R to form plaques without trypsin addition.
Literature
1.
go back to reference Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259PubMed Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73:251–259PubMed
2.
go back to reference Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (1995) A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J 14:6087–6094PubMed Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (1995) A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J 14:6087–6094PubMed
3.
go back to reference Ishida N, Homma M (1978) Sendai virus. Adv. Virus Res 23:349–383 Ishida N, Homma M (1978) Sendai virus. Adv. Virus Res 23:349–383
4.
go back to reference Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, Nagai Y (1996) Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569–579CrossRefPubMed Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, Nagai Y (1996) Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569–579CrossRefPubMed
5.
go back to reference Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, Fukutomi A, Katunuma N (1992) Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells: a possible activator of the viral fusion glycoprotein. J Biol Chem 267:13573–13579PubMed Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, Fukutomi A, Katunuma N (1992) Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells: a possible activator of the viral fusion glycoprotein. J Biol Chem 267:13573–13579PubMed
6.
go back to reference Leyrer S, Neubert WJ, Sedlmeier R (1998) Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J Virol Methods 75:47–58CrossRefPubMed Leyrer S, Neubert WJ, Sedlmeier R (1998) Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J Virol Methods 75:47–58CrossRefPubMed
7.
go back to reference Middleton Y, Tashiro M, Thai T, Oh J, Seymour J, Pritzer E, Klenk H-D, Rott R, Seto JT (1990) Nucleotide sequence analyses of the genes encoding the HN, M, NP, and L proteins of two host range mutants of Sendai virus. Virology 176:656–657CrossRefPubMed Middleton Y, Tashiro M, Thai T, Oh J, Seymour J, Pritzer E, Klenk H-D, Rott R, Seto JT (1990) Nucleotide sequence analyses of the genes encoding the HN, M, NP, and L proteins of two host range mutants of Sendai virus. Virology 176:656–657CrossRefPubMed
8.
go back to reference Okada H, Seto JT, McQueen NL, Klenk H-D, Rott R, Tashiro M (1998) Determinants of pantropism of the F1-R mutant of Sendai virus: specific mutations involved are in the F and M genes. Arch Virol 143:2343–2352CrossRefPubMed Okada H, Seto JT, McQueen NL, Klenk H-D, Rott R, Tashiro M (1998) Determinants of pantropism of the F1-R mutant of Sendai virus: specific mutations involved are in the F and M genes. Arch Virol 143:2343–2352CrossRefPubMed
9.
go back to reference Rimmelzwaan G F, Baars M, Claas ECJ, Osterhaus ADME (1998) Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 74:57–66CrossRefPubMed Rimmelzwaan G F, Baars M, Claas ECJ, Osterhaus ADME (1998) Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 74:57–66CrossRefPubMed
10.
go back to reference Segawa H, Yamashita T, Kawakita M, Taira H (2000) Functional analysis of the individual oligosaccharide chains of Sendai virus fusion protein. J Biochem 128:65–72PubMed Segawa H, Yamashita T, Kawakita M, Taira H (2000) Functional analysis of the individual oligosaccharide chains of Sendai virus fusion protein. J Biochem 128:65–72PubMed
11.
go back to reference Tashiro M, Homma M (1983) Pneumotropism of Sendai virus in relation to protease- mediated activation in mouse lungs. Infect Immun 39:879–888PubMed Tashiro M, Homma M (1983) Pneumotropism of Sendai virus in relation to protease- mediated activation in mouse lungs. Infect Immun 39:879–888PubMed
12.
go back to reference Tashiro M, Homma M (1983) Evidence of proteolytic activation of Sendai virus in mouse lung. Arch Virol 77:127–137PubMed Tashiro M, Homma M (1983) Evidence of proteolytic activation of Sendai virus in mouse lung. Arch Virol 77:127–137PubMed
13.
go back to reference Tashiro M, Pritzer E, Koshnan MA, Yamakawa M, Kuroda K, Klenk H-D, Rott R, Seto JT (1988) Characterization of a pantropic variant of Sendai virus derived from a host-range mutant. Virology 165:577–583CrossRefPubMed Tashiro M, Pritzer E, Koshnan MA, Yamakawa M, Kuroda K, Klenk H-D, Rott R, Seto JT (1988) Characterization of a pantropic variant of Sendai virus derived from a host-range mutant. Virology 165:577–583CrossRefPubMed
14.
go back to reference Tashiro M, Yamakawa M, Tobita K, Klenk H-D, Rott R, Seto JT (1990) Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J Virol 64:3627–3634PubMed Tashiro M, Yamakawa M, Tobita K, Klenk H-D, Rott R, Seto JT (1990) Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J Virol 64:3627–3634PubMed
15.
go back to reference Tashiro M, Yamakawa M, Tobita K, Klenk H-D, Rott R, Seto JT (1990) Altered budding site of a pantropic mutant of Sendai virus, F1-R, in the polarized epithelial cells. J Virol 64:4672–4677PubMed Tashiro M, Yamakawa M, Tobita K, Klenk H-D, Rott R, Seto JT (1990) Altered budding site of a pantropic mutant of Sendai virus, F1-R, in the polarized epithelial cells. J Virol 64:4672–4677PubMed
16.
go back to reference Tashiro M, James I, Karri S, Wahn K, Tobita K, Klenk H-D, Rott R, Seto JT (1991) Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus. Virology 184:227–234PubMed Tashiro M, James I, Karri S, Wahn K, Tobita K, Klenk H-D, Rott R, Seto JT (1991) Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus. Virology 184:227–234PubMed
17.
go back to reference Tashiro M, Seto JT, Choosakul S, Hegemann H, Klenk H-D, Rott R (1992) Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice. J Gen Virol 73:1575–1579PubMed Tashiro M, Seto JT, Choosakul S, Hegemann H, Klenk H-D, Rott R (1992) Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice. J Gen Virol 73:1575–1579PubMed
18.
go back to reference Tashiro M, Seto JT, Choosakul S, Yamakawa M, Klenk H-D, Rott R (1992) Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice. Virology 187:413–422CrossRefPubMed Tashiro M, Seto JT, Choosakul S, Yamakawa M, Klenk H-D, Rott R (1992) Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice. Virology 187:413–422CrossRefPubMed
19.
go back to reference Tashiro M, Yamakawa M, Tobita K, Klenk H-D, Seto JT, Rott R (1992) Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusion. Arch Virol 125:129–139PubMed Tashiro M, Yamakawa M, Tobita K, Klenk H-D, Seto JT, Rott R (1992) Significance of basolateral domain of polarized MDCK cells for Sendai virus-induced cell fusion. Arch Virol 125:129–139PubMed
20.
go back to reference Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H (1992) Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol 66:7211–7216PubMed Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H (1992) Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol 66:7211–7216PubMed
21.
go back to reference Tashiro M, Seto JT, Klenk H-D, Rott R (1993) Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells. J Virol 67–5902–5910 Tashiro M, Seto JT, Klenk H-D, Rott R (1993) Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells. J Virol 67–5902–5910
22.
go back to reference Tashiro M, McQueen NL, Seto JT, Klenk H-D, Rott R (1996) Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J Virol. 90:5990–5997 Tashiro M, McQueen NL, Seto JT, Klenk H-D, Rott R (1996) Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J Virol. 90:5990–5997
23.
go back to reference Wagner R, HeuerD, Wolff T, Herwig A, Klenk H-D (2002) N-Glycans attached to the stem domain of the hemagglutinin efficiently regulate influenza A virus replication. J Gen Virol 83:601–609PubMed Wagner R, HeuerD, Wolff T, Herwig A, Klenk H-D (2002) N-Glycans attached to the stem domain of the hemagglutinin efficiently regulate influenza A virus replication. J Gen Virol 83:601–609PubMed
Metadata
Title
Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin
Authors
Xiaogang Hou
Edgar Suquilanda
Ana Zeledon
Apollo Kacsinta
Akila Moore
Joseph Seto
Nancy McQueen
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 3/2005
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-004-0224-3

Other articles of this Issue 3/2005

Medical Microbiology and Immunology 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.